Purchase Order 15B50525P00000089

Award Date 5/1/25
Potential Completion Date 5/31/25
Potential Value $22K
Ultimate Awardee
Mckesson Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cary, NC 27513, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $21,535.58 firm fixed price purchase order awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a for-profit pharmaceutical company, on January 10, 2025. The order is for the delivery of cancer drugs and biologics, with an ultimate completion date of January 10, 2025. Biologics, Inc. is a subsidiary of the larger McKesson Corporation, which is also a for-profit healthcare services and information technology company that holds various...
This is a firm fixed-price purchase order contract awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc. to provide the cancer drug TURALIO 125MG. The order is for delivery during Fiscal Year 2025 with a completion date of February 18, 2025 and a ceiling value of $22,061.05. Biologics, Inc. is a for-profit organization that has previously held federal contracts to supply specialty pharmaceuticals to agencies such as the Department of Veterans Affairs and the...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 19 (VISN 19), a civilian agency under the Department of Veterans Affairs (VA), to Mckesson Plasma And Biologics LLC, a for-profit limited liability company, for pharmaceutical products and medical supplies. The contract has a total ceiling value of $103,728.96 and a completion date of June 30, 2015. The contract does not have a set-aside designation. Mckesson Plasma And Biologics LLC, a subsidiary of...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 1 (VISN 1), a division of the Department of Veterans Affairs (VA), to Mckesson Plasma And Biologics LLC, a for-profit limited liability company. The contract, valued at $145,440.00, is for the provision of pharmaceutical medications to support direct patient care for specific patients. The contract has an ultimate completion date of February 25, 2016. Mckesson Plasma And Biologics LLC, a subsidiary of...
This federal contract award was issued by the Federal Medical Center Carswell, a civilian agency, to the prime contractor Mckesson Corporation, doing business as Mckesson. The contract, valued at $71,844.42, is for the delivery of pharmaceutical drugs to the agency during fiscal year 2024. It is a firm fixed price delivery order contract with an ultimate completion date of August 1, 2024. No set-aside designations were used. Mckesson Corporation is a healthcare services and information...
This firm fixed price purchase order for $1,748.03 was awarded by the Department of Justice Bureau of Prisons to McKesson Plasma and Biologics LLC for open market medications to be delivered under the HEALTH SERVICES B1 vehicle. McKesson Plasma and Biologics, a subsidiary of McKesson Corporation which does business as McKesson Drug Company, will provide medications to the Federal Correctional Institution in Edgefield, South Carolina for the third quarter of fiscal year 2023. Delivery is required...
This is a firm fixed-price delivery order awarded by the Federal Medical Center Carswell, a civilian agency, to McKesson Corporation for the provision of various medications for the month of September 2015. The contract has a ceiling value of $305,000.00 and an ultimate completion date of September 30, 2015. The contract was not set aside for any specific business category. McKesson Corporation is a healthcare services and information technology company that provides pharmaceuticals, medical...
This is a firm fixed price delivery order awarded by the Federal Medical Center Carswell, a civilian agency within the Department of Justice, to the prime contractor Mckesson Corporation. The $4,367,000.00 contract is for the provision of various medications during fiscal year 2016 and has an ultimate completion date of September 30, 2016. No set-aside designation was used. The award is associated with a larger indefinite delivery/indefinite quantity contract vehicle that Mckesson has used to...
This is a firm fixed-price purchase order awarded by the Federal Correctional Complex Pollock, part of the Department of Justice's Bureau of Prisons, to Mckesson Corporation, a large healthcare services and IT company, for the provision of pharmaceuticals. The contract has a ceiling value of $5,603.86 and a completion date of April 22, 2025. The contract was not set aside for any socioeconomic program. Mckesson is the prime contractor, and the award indicates the company's extensive...
This federal contract award is for the delivery of pharmaceutical products and medical supplies to various government agencies by Mckesson Corporation, a healthcare services and information technology company. The $1,316.47 firm fixed price purchase order was awarded on October 22, 2024 with a completion date of September 30, 2025. Mckesson is the prime contractor on this open market award, with no set-aside designation. The company has a history of providing pharmaceuticals, medical supplies,...

This is a firm fixed-price purchase order contract awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a subsidiary of McKesson Corporation, for the supply of cancer drugs and biologics during fiscal year 2025. The contract has a ceiling value of $22,061.05 and an ultimate completion date of May 31, 2025. There is no set-aside designation for this contract, indicating open competition. Biologics, Inc. is a for-profit pharmaceutical company that specializes in providing specialty pharmaceuticals and medical drugs, with a focus on delivering cancer treatment medications and other critical pharmaceutical products to various federal agencies, including the Department of Veterans Affairs and the Department of Justice. This contract award demonstrates Biologics, Inc.'s role as a key distributor of specialized medical treatments, leveraging its parent company's extensive network and experience in healthcare supply and distribution.

Generated 7/1/25, 12:43 PM